BIOLINERX     Print Page  Close Window

SEC filings
F-3
BIOLINERX LTD. filed this Form F-3 on 07/16/2015
Entire Document
 
zk1517058.htm
 
As filed with the Securities and Exchange Commission on July 16, 2015.
 
Registration No. 333-


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
__________________________
 
FORM F-3
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
__________________________
 
BIOLINERX LTD.
(Exact Name of Registrant as Specified in its Charter)
 
State of Israel
2834
Not Applicable
(State or other jurisdiction of
incorporation or organization)
(Primary Standard Industrial
Classification Code Number)
(I.R.S. Employer Identification No.)
__________________________
 
BioLineRx Ltd.
Modi’in Technology Park
2 HaMa’ayan Street
Modi’in 7177871, Israel
(972) (8) 642-9100
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Vcorp Services, LLC
25 Robert Pitt Drive, Suite 204
 Monsey, New York 10952
(Name, Address, including zip code, and telephone number, including area code, of agent for service)
 
Copies of all correspondence to:
 
Anna T. Pinedo, Esq.
James R. Tanenbaum, Esq.
Morrison & Foerster LLP
250 West 55th Street
New York, New York 10019-5201
Tel: (212) 468-8000
Barry Levenfeld, Adv.
Eric Spindel, Adv.
Yigal Arnon & Co.
22 Rivlin Street
Jerusalem 94240, Israel
Tel: (972) (2) 623-9220
   
Approximate date of commencement of proposed sale to the public: From time to time after this Registration Statement becomes effective.
 
If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please cheek the following box. o
 
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. x